A new paper published in New England Journal of Medicine details how an 18-year-old patient being treated at BC Children’s Hospital (BCCH) for a rare disease called chronic granulomatous disease (CGD) became the first person ever to receive and be cured by a gene modification treatment known as “Prime Editing.”
Born and raised in Johannesburg, Dr. Alastair McAlpine, a researcher with the Vaccine Evaluation Center (VEC) at BC Children’s Hospital Research Institute (BCCHR), is passionate about pediatric palliative care and infectious diseases. He received his medical training in South Africa, but limited vacancies to pursue a specialization in his desired field brought him to Vancouver. After meeting a…
February 15 was International Childhood Cancer Day and to mark the occasion we spoke with Dr. Sarah Alexander, a new BCCHR investigator and pediatric oncologist at BC Children’s Hospital who specializes in some of the most common childhood cancers, including non-Hodgkin lymphoma and acute lymphoblastic leukemia (ALL).
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.